References
- Llano E, Pendas A M, Freije J P, Nakano A, Knauper V, Murphy G, Lopez-Otin C. Identification and characterization of human MT5-MMP, a new membrane-bound activator of progelatinase a overexpressed in brain tumors. Cancer Res 1999; 59: 2570–2576
- Lee M H, Murphy G. Matrix metalloproteinases at a glance. J Cell Sci 2004; 117: 4015–4016
- Curry T E, Osteen K G. Cyclic changes in the metalloproteinase system in the ovary and uterus. Biol Reprod 2001; 64: 1285–1296
- Plaisier M, Koolwijk P, Hanemaaijer R, Verwey R A, van der Weiden R MF, Risse E KJ, Jungerius C, Helmerhorst F M, Van Hinsbergh V WM. Membrane-type matrix metalloproteinases and vascularization in human endometrium during the menstrual cycle. Mol Hum Reprod 2006; 12: 11–18
- Galant C, Berliere M, Dubois D, Verougstraete J C, Charles A, Lemoine P, Kokorine I, Eeckhout Y, Courtoy P J, Marbaix E. Focal expression and final activity of matrix metalloproteinases may explain irregular dysfunctional endometrial bleeding. Am J Pathol 2004; 165: 83–94
- Graesslin O, Cortez A, Fauvet R, Lorenzato M, Birembaut P, Darai E. Metalloproteinase-2, -7 and -9 and tissue inhibitor of metalloproteinase-1 and -2 expression in normal, hyperplastic and neoplastic endometrium: a clinical–pathological correlation study. Ann Oncol 2006; 17: 637–645
- Li T, Li Y G, Pu D M. Matrix metalloproteinase-2 and -9 expression correlated with angiogenesis in human adenomyosis. Gynecol Obstet Invest 2006; 62: 229–235
- Malik S, Day K, Perrault I, Charnock-Jones D S, Smith S K. Reduced levels of VEGF-A and MMP-2 and MMP-9 activity and increased TNF-α in menstrual endometrium and effluent in women with menorrhagia. Hum Reprod 2006; 21: 2158–2166
- Rody A, Holtrich U, Gatje R, Gehrmann M, Engels K, von Minckwitz G, Loibl S, Diallo-Danebrock R, Ruckhaberle E, Metzler D, et al. Poor outcome in estrogen receptor-positive breast cancers predicted by loss of plexin B1. Clin Cancer Res 2007; 13: 1115–1122
- Eisen M B, Spellman P T, Brown P O, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998; 95: 14863–14868
- Gaetje R, Holtrich U, Engels K, Kissler S, Rody A, Karn T, Kaufmann M. Endometriosis may be generated by mimicking the ontogenetic development of the female genital tract. Fertil Steril 2007; 87: 651–656
- Chung H W, Wen Y, Chun S H, Nezhat C, Woo B H, Lake Polan M. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-3 mRNA expression in ectopic and eutopic endometrium in women with endometriosis: a rationale for endometriotic invasiveness. Fertil Steril 2001; 75: 152–159
- Hayashita-Kinoh H, Kinoh H, Okada A, Komori K, Itoh Y, Chiba T, Kajita M, Yana I, Seiki M. Membrane-type 5 matrix metalloproteinase is expressed in differentiated neurons and regulates axonal growth. Cell Growth Differ 2001; 12: 573–580
- Chung H W, Lee J Y, Moon H S, Hur S E, Park M H, Wen Y, Polan M L. Matrix metalloproteinase-2, membranous type 1 matrix metalloproteinase, and tissue inhibitor of metalloproteinase-2 expression in ectopic and eutopic endometrium. Fertil Steril 2002; 78: 787–795
- Collette T, Bellehumeur C, Kats R, Maheux R, Mailloux J, Villeneuve M, Akoum A. Evidence for an increased release of proteolytic activity by the eutopic endometrial tissue in women with endometriosis and for involvement of matrix metalloproteinase-9. Hum Reprod 2004; 19: 1257–1264
- Collette T, Maheux R, Mailloux J, Akoum A. Increased expression of matrix metalloproteinase-9 in the eutopic endometrial tissue of women with endometriosis. Hum Reprod 2006; 21: 3059–3067